CUSIP 29337E102COMELVNQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
126 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 7.96M | $122.58M | 0 | Held |
| 2 | Fmr LLC | 7.11M | $109.46M | −21.6K | Reduced |
| 3 | Commodore Capital LP | 4.69M | $72.27M | 0 | Held |
| 4 | Vestal Point Capital, LP | 3.83M | $58.98M |
| +2.67M |
| Added |
| 5 | Fairmount Funds Management LLC | 3.71M | $57.16M | 0 | Held |
| 6 | Blackrock, Inc. | 3.61M | $55.65M | +94.8K | Added |
| 7 | Polar Capital Holdings PLC | 3.51M | $54.11M | +418.7K | Added |
| 8 | Vr Adviser, LLC | 3.23M | $49.69M | 0 | Held |
| 9 | Vanguard Group Inc | 2.80M | $43.15M | +248.7K | Added |
| 10 | Janus Henderson Group PLC | 1.67M | $25.74M | −121.9K | Reduced |
See every fund holding Enliven Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders